EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tolerability and Feasibility of Minimally Invasive Canine Skin Sampling: Excellent Tolerability Meets Transcriptomic Challenges

Ina Herrmann iD, Lisa B Mamo, Allison N Dickey iD

Veterinary Dermatology · 2026

DOI: 10.1111/vde.70044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Dermatology, 2026. Verfasst von Ina Herrmann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Skin, Dog Diseases, Transcriptome, Specimen Handling. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: American College of Veterinary Dermatology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advances in transcriptomics have driven the demand for minimally invasive, reproducible and high‐yield skin sampling methods, particularly for studying inflammatory skin diseases in companion animals. Hypothesis/Objectives We tested tolerability, feasibility and RNA quantity and quality of three minimally invasive skin sampling techniques. Animals Nine privately‐owned dogs, including healthy individuals and those diagnosed with canine atopic dermatitis. Materials and Methods The tolerability and feasibility of three minimally invasive skin sampling techniques—microbiopsy (MB) collection, skin‐scraping (SS) and tape‐stripping (TS)—were tested in a clinical setting. RNA quantity and quality (RIN) were measured. Quality control and potential contamination were evaluated during downstream RNA sequencing.

Results

All techniques were well‐tolerated, and sampling was feasible in a clinical setting. RNA yield and quality varied significantly. Microbiopsy and SS samples yielded low RNA quantities with poor integrity. Tape‐stripping samples produced the highest RNA concentration and integrity (RIN 3.4–7.1) yet showed notable variability. Although initial sequencing quality thresholds were met, downstream transcriptomic analysis of the TS samples was limited by uneven degradation and suspected DNA contamination. Conclusions and Clinical Relevance Minimally invasive skin sampling methods are feasible and well‐tolerated in dogs. Among the techniques evaluated, TS showed the most potential for transcriptomic applications. However, RNA quality remains a key limitation. Further refinement in sample processing and handling is essential to improve consistency and enable reliable downstream analyses in veterinary dermatological research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SkinDog DiseasesTranscriptomeSpecimen HandlingDermatitis, AtopicAnimalsDogsFeasibility StudiesFemaleRNAMale

Stichwörter der Autor:innen

D‐squameRNA sequencingmicrobiopsyskin‐scrapingtape‐stripping

Substanzen

RNA

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Ina Herrmann, Allison N Dickey

Förderung

  • American College of Veterinary Dermatology

Zitieren

APA

Herrmann, I., Mamo, L. B., & Dickey, A. N. (2026). Tolerability and Feasibility of Minimally Invasive Canine Skin Sampling: Excellent Tolerability Meets Transcriptomic Challenges. Veterinary Dermatology. https://doi.org/10.1111/vde.70044

Vancouver

Herrmann I, Mamo LB, Dickey AN. Tolerability and Feasibility of Minimally Invasive Canine Skin Sampling: Excellent Tolerability Meets Transcriptomic Challenges. Veterinary Dermatology. 2026. doi:10.1111/vde.70044

BibTeX
@article{Herrmann2026,
  author = {Herrmann, Ina and Mamo, Lisa B and Dickey, Allison N},
  title = {Tolerability and Feasibility of Minimally Invasive Canine Skin Sampling: Excellent Tolerability Meets Transcriptomic Challenges},
  journal = {Veterinary Dermatology},
  year = {2026},
  doi = {10.1111/vde.70044}
}
Kostenlos starten →